Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/55494
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Prevalence of CYP2C9 polymorphisms in the south of EuropePrevalence of CYP2C9 polymorphisms in Europe

AutorSánchez-Diz, Paula; Velasco, Eladio CSIC ORCID
Fecha de publicaciónoct-2009
EditorNature Publishing Group
CitaciónPharmacogenomics Journal 9(5): 306-310 (2009)
ResumenCYP2C9 is a major liver enzyme responsible of the metabolism of many clinically important drugs. The presence of CYP2C9 genetic polymorphisms has been associated with marked interindividual variability in its catalytic activity that could result in drug toxicity. Here we present frequencies of the most common CYP2C9 coding variants CYP2C9*2 (C430T) and CYP2C9*3 (A1075C) in representative samples of four regions from Spain (Basque Country, n=358; Catalonia, n=240; Central Spain, n=190 and Galicia, n=288) and one northern Italian region, (Verona, n=164), which range between 0.125 and 0.165 in the case of CYP2C9*2 and between 0.071 and 0.085 for CYP2C9*3. No significant differences between CYP2C9 allele frequencies were found comparing all the sampled populations. A more extensive comparative analysis using allele frequency data of populations widely spread over Europe was performed, showing significant differences in the CYP2C9*2 allele frequencies distribution between some of the regions, being quite homogeneous in the case of CYP2C9*3 variant. The results obtained show that above 40% of our samples carry a mutate allele, which can result in a poor metabolization of low therapeutic index drugs as oral anticoagulants (warfarin, acenocoumarol), oral antidiabetic drugs and some non-steroidal anti-inflammatory drugs. Our study constitutes both a large (n=1240) and robust allele frequency database on CYP2C9 polymorphisms, which represents one of the most numerous CYP2C9*2 and *3 database existing to date.
Descripción5 páginas.-- et al.
Versión del editorhttp://dx.doi.org/10.1038/tpj.2009.16
URIhttp://hdl.handle.net/10261/55494
DOI10.1038/tpj.2009.16
ISSN1470-269X
E-ISSN1473-1150
Aparece en las colecciones: (IBGM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

26
checked on 12-abr-2024

WEB OF SCIENCETM
Citations

22
checked on 27-feb-2024

Page view(s)

307
checked on 19-abr-2024

Download(s)

73
checked on 19-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.